October 3, 2011

AMGEN INC: Teva ‘603 Patent Litigation Dismissed in July 2011

COMPANIES: Amgen Inc
Subscribe

Patent litigation between Teva and Amgen Inc. has been dismissed, the Company disclosed in its August 8, 2011 Form 10-Q filing with the U.S. Securities and Exchange Commission for the…

TO CONTINUE READING,LOGIN or
TOPICS: Drugs/Pharmaceuticals | Legal Issues, Litigation | Patents, Intellectual Prop. | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: Pennsylvania | United States